Gene · 8065
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sulfated Polysaccharide Regulates the Homing of HSPCs in a BMP-2-Triggered In Vivo Osteo-Organoid. | Adv Sci (Weinh) | 2023 | 37357138 | PubTator, text mining | PubMed |
| Progress and Perspective of CRISPR-Cas9 Technology in Translational Medicine. | Adv Sci (Weinh) | 2023 | 37356052 | PubTator, text mining | PubMed |
| Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. | Nat Commun | 2023 | 37353483 | PubTator, text mining | PubMed |
| FBXO7, a tumor suppressor in endometrial carcinoma, suppresses INF2-associated mitochondrial division. | Cell Death Dis | 2023 | 37344480 | PubTator, text mining | PubMed |
| Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma. | J Cell Mol Med | 2023 | 37315184 | PubTator, text mining | PubMed |
| Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancers. | Front Oncol | 2023 | 37274282 | PubTator, text mining | PubMed |
| Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia. | Int J Mol Sci | 2023 | 37240440 | PubTator, text mining | PubMed |
| The Role of Peroxiredoxins in Cancer Development. | Biology (Basel) | 2023 | 37237480 | PubTator, text mining | PubMed |
| Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients. | J Transl Med | 2023 | 37210557 | PubTator, text mining | PubMed |
| Molecular evolution of Keap1 was essential for adaptation of vertebrates to terrestrial life. | Sci Adv | 2023 | 37205751 | PubTator, text mining | PubMed |
| Syringic acid demonstrates an anti-inflammatory effect via modulation of the NF-κB-iNOS-COX-2 and JAK-STAT signaling pathways in methyl cellosolve-induced hepato-testicular inflammation in rats. | Biochem Biophys Rep | 2023 | 37197735 | PubTator, text mining | PubMed |
| Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer. | Cancers (Basel) | 2023 | 37174034 | PubTator, text mining | PubMed |
| FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors. | EMBO J | 2023 | 37161784 | PubTator, text mining | PubMed |
| JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences. | J Clin Immunol | 2023 | 37140667 | PubTator, text mining | PubMed |
| The interactions between PML nuclear bodies and small and medium size DNA viruses. | Virol J | 2023 | 37127643 | PubTator, text mining | PubMed |
| Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy. | Front Oncol | 2023 | 37124491 | PubTator, text mining | PubMed |
| Identification and characterization of the CDK1-BMAL1-UHRF1 pathway driving tumor progression. | iScience | 2023 | 37123229 | PubTator, text mining | PubMed |
| The Involvement of Ubiquitination and SUMOylation in Retroviruses Infection and Latency. | Viruses | 2023 | 37112965 | PubTator, text mining | PubMed |
| A novel protein encoded by circINSIG1 reprograms cholesterol metabolism by promoting the ubiquitin-dependent degradation of INSIG1 in colorectal cancer. | Mol Cancer | 2023 | 37087475 | PubTator, text mining | PubMed |
| Targeting neddylation as a novel approach to lung cancer treatment (Review). | Int J Oncol | 2023 | 37083098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8065/papers?page=8